Gilead Sciences, Inc. Financial Ratios — GILD.SW Stock

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Return on Common Equity (%)	189.3	94.53	62.66	128.45	117.83	74.68	24.9	28.68	28.04	0.73	40.54	28.69	35.41	3.45	67.46
Return on Assets (%)	19.41	13.45	14.04	42.28	41.93	24.84	7.27	8.14	8.6	0.19	9.13	7	9.04	0.79	14.42
Return on Capital (%)	41.2	26.44	26.22	64.57	56.48	33.35	10.24	12.52	- -	0.47	15.76	12.76	15.81	2.92	24.51
Return on Invested Capital (%)	24.36	17.96	18.43	53.74	54.43	32.6	9.75	12.67	- -	1.1	16.76	18.29	15.25	15.52	21.77
Gross Margin (%)	74.67	74.53	74.48	84.78	87.73	85.98	83.26	78.07	79.18	81.48	75.82	79.26	76.04	78.26	78.83
EBITDA Margin (%)	48.8	44.2	43.47	65.55	71.36	61.83	59.03	48.48	47.85	46.2	47.27	47.93	42.52	46.47	49.12
Operating Margin (%)	45.2	41.33	40.39	61.33	68	58.02	54.1	42.02	41.6	40.21	39.76	40.23	32.59	36.85	39.74
Incremental Operating Margin (%)	-39.54	16.72	34.27	78.47	89.41	202.76	81.93	121.26	12.42	26.29	35.55	-487.5	1,294.55	107.33	160.61
Pretax Margin (%)	43.54	37.23	37.56	59.69	66.36	56.26	51.82	35.25	22.99	6.76	30.32	21.31	25.3	2.4	33.27
Profit Margin (%)	33.43	26.72	27.45	48.62	55.48	44.43	17.73	24.65	23.99	0.5	22.8	16.83	20.89	1.67	28.9
Net Income to Common Margin (%)	33.43	26.72	27.45	48.62	55.48	44.43	17.73	24.65	23.99	0.5	22.8	16.83	20.89	1.67	28.9
Effective Tax Rate (%)	23.61	28.74	27.35	18.83	16.4	21.11	65.67	29.99	- -	94.67	25.09	21.47	18.18	30.58	13.13
Dvd Payout Ratio (%)	- -	- -	- -	- -	10.35	18.22	58.61	54.36	60.31	6,270.91	58.36	81.7	68.51	817.95	47.04
Sustainable Growth Rate (%)	189.3	94.53	62.66	128.45	105.63	61.07	10.31	13.09	11.13	-44.95	16.88	5.25	11.15	-24.79	35.73

Credit (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Total Debt	7,607	8,224	6,636	12,404	22,055	26,346	33,542	27,322	24,593	31,402	26,695	25,230	24,987	26,711	24,936
ST Debt	2	1,169	2,697	483	982	- -	2,747	2,748	2,499	2,757	1,516	2,273	1,798	1,815	2,807
LT Debt	7,606	7,055	3,939	11,921	21,073	26,346	30,795	24,574	22,094	28,645	25,179	22,957	23,189	24,896	22,129
Total Debt/EBITDA	1.86	1.92	1.36	0.76	0.95	1.4	2.18	2.55	2.29	2.75	2.07	1.93	2.17	2	1.72
Net Debt/EBITDA	-0.56	1.5	0.93	0.15	0.4	0.96	1.68	0.87	1.21	2.23	1.65	1.52	1.64	1.25	1.2
Total Debt/EBIT	2.01	2.05	1.47	0.81	0.99	1.49	2.37	2.94	2.63	3.16	2.46	2.3	2.83	2.52	2.13
Net Debt/EBIT	-0.6	1.6	1	0.16	0.41	1.03	1.84	1.01	1.39	2.56	1.97	1.81	2.14	1.58	1.48
EBITDA to Interest Expense	19.92	11.88	15.86	39.6	33.85	19.49	13.78	9.96	10.8	11.59	12.89	13.99	12.22	13.68	14.12
EBITDA-CapEx/Interest Expense	19.92	11.88	15.86	39.6	33.85	19.49	13.78	9.96	10.8	11.59	12.89	13.99	11.6	13.14	13.57
EBIT to Interest Expense	18.45	11.11	14.74	37.05	32.26	18.29	12.63	8.63	9.38	10.09	10.85	11.74	9.36	10.85	11.43
Interest Expense	205	361	307	412	688	964	1,118	1,077	995	984	1,001	935	944	977	1,024
Common Equity/Total Assets	10.27	17.45	27.05	36.74	34.81	31.86	27.05	29.88	31.46	21.02	24.02	24.83	26.25	19.49	23.26
Long-Term Debt/Equity (%)	110.75	73.92	33.54	75.36	110.25	136.06	150.21	114.12	97.55	157.21	119.54	108.24	101.93	129.36	97.84
Long-Term Debt/Capital (%)	79.95	57.96	30.03	46.69	51.86	58.58	58.53	52.85	50.09	62.54	58.54	56.15	56.27	65.3	57.35
Long-Term Debt/Total Assets (%)	43.96	33.21	17.45	34.39	40.75	46.24	43.82	38.59	35.85	41.87	37.05	36.34	37.33	42.2	37.49
Total Debt/Equity (%)	110.78	86.17	56.5	78.41	115.39	136.06	163.61	126.88	108.58	172.34	126.73	118.96	109.84	138.79	110.25
Total Debt/Capital (%)	79.96	67.57	50.58	48.58	54.27	58.58	63.75	58.76	55.76	68.56	62.06	61.71	60.64	70.06	64.63
Total Debt/Total Assets (%)	43.96	38.72	29.39	35.78	42.65	46.24	47.72	42.91	39.91	45.9	39.29	39.94	40.22	45.28	42.25
Net Debt to Equity	-33.15	67.27	38.51	15.03	48.16	93.57	126.6	43.57	57.23	139.43	101.39	93.44	83.09	86.88	76.81
Net Debt/Capital (%)	614.49	61.93	41.1	15.33	33.13	49.3	57.64	32.86	39.91	63.82	56.68	55.86	53.82	59.43	56
EBITDA	4,092	4,288	4,869	16,315	23,291	18,791	15,410	10,727	10,742	11,407	12,907	13,077	11,531	13,363	14,461
EBITDA-CapEx	4,092	4,288	4,869	16,315	23,291	18,791	15,410	10,727	10,742	11,407	12,907	13,077	10,946	12,840	13,898
Operating Income (Loss)	3,790	4,010	4,524	15,265	22,193	17,633	14,124	9,298	9,338	9,927	10,857	10,974	8,838	10,596	11,701

Liquidity (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Cash Ratio	3.94	0.44	0.33	1.76	1.48	1.29	2.19	2.84	2.5	0.65	0.56	0.57	0.64	0.96	0.81
Current Ratio	5.53	1.45	1.09	3.07	2.5	2.12	2.74	3.38	3.1	1.4	1.27	1.29	1.43	1.6	1.55
Quick Ratio	4.71	0.85	0.67	2.56	2.07	1.78	2.52	3.15	2.86	1.08	0.95	0.99	1.06	1.33	1.23
CFO/Avg Current Liab	1.46	0.95	0.58	2.11	2.72	1.78	1.14	0.76	0.9	0.77	0.99	0.79	0.71	0.93	0.84
Common Equity/Total Assets	10.27	17.45	27.05	36.74	34.81	31.86	27.05	29.88	31.46	21.02	24.02	24.83	26.25	19.49	23.26
Long-Term Debt/Equity (%)	110.75	73.92	33.54	75.36	110.25	136.06	150.21	114.12	97.55	157.21	119.54	108.24	101.93	129.36	97.84
Long-Term Debt/Capital (%)	79.95	57.96	30.03	46.69	51.86	58.58	58.53	52.85	50.09	62.54	58.54	56.15	56.27	65.3	57.35
Long-Term Debt/Total Assets (%)	43.96	33.21	17.45	34.39	40.75	46.24	43.82	38.59	35.85	41.87	37.05	36.34	37.33	42.2	37.49
Total Debt/Equity (%)	110.78	86.17	56.5	78.41	115.39	136.06	163.61	126.88	108.58	172.34	126.73	118.96	109.84	138.79	110.25
Total Debt/Capital (%)	79.96	67.57	50.58	48.58	54.27	58.58	63.75	58.76	55.76	68.56	62.06	61.71	60.64	70.06	64.63
Total Debt/Total Assets (%)	43.96	38.72	29.39	35.78	42.65	46.24	47.72	42.91	39.91	45.9	39.29	39.94	40.22	45.28	42.25
CFO/Total Liabilities	34.87	27.32	28.66	68.02	65.18	45.32	23.9	19.93	23.46	16.28	24.28	21.62	20.33	27.24	27.52
CFO/CapEx	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	13.69	20.7	17.8
Altman's Z-Score	2.43	3.6	3.72	4.79	3.7	2.7	2.52	2.5	2.4	3.06	3.43	3.44	3.1	2.88	2.82

Working Capital (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Accounts Receivable Turnover	4.69	5.24	5.7	7.3	6.22	5.86	6.24	6.17	6.5	5.83	5.82	5.89	5.75	6.33	6.31
Days Sales Outstanding	77.77	69.65	64.08	49.98	58.65	62.26	58.48	59.2	56.17	62.64	62.73	62.01	63.51	57.63	57.85
Inventory Turnover	1.64	1.58	1.66	2.46	2.4	2.41	3.66	6.01	5.39	3.51	4	3.62	3.95	3.58	3.58
Days Inventory Outstanding	222.82	231.54	219.71	148.53	152.2	151.7	99.7	60.73	67.77	103.98	91.26	100.82	92.51	102.1	101.99
Accounts Payable Turnover	2.3	2.23	2.18	3.15	4.29	3.27	3.55	6.07	6.36	6.85	8.44	6.89	9.32	8.93	8.14
Accounts Payable Turnover Days	158.69	163.6	167.72	116.05	85.09	111.76	102.83	60.16	57.35	53.28	43.25	52.98	39.18	40.88	44.86
Cash Conversion Cycle	141.9	137.58	116.08	82.47	125.77	102.21	55.35	59.78	66.59	113.34	110.74	109.85	116.85	118.85	114.99
Inventory to Cash Days	-145.06	-161.89	-155.63	-98.55	-93.56	-89.44	-41.23	-1.53	-11.6	-41.34	-28.54	-38.8	-29	-44.47	-44.14
Inventories	1,390	1,745	1,697	1,386	1,955	1,587	801	814	922	1,683	1,618	1,507	1,787	1,710	1,774
Raw Materials	698	827	1,049	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	466	359	413	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	226	560	593	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	-359	1,386	1,955	1,587	801	814	922	1,683	1,618	1,507	1,787	1,710	1,774

Enterprise Value (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Market Capitalization	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
- Cash & Cash Equivalents	9,884	1,804	2,113	10,027	12,851	8,229	7,588	17,940	11,631	5,997	5,338	5,412	6,085	9,991	7,564
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	128	241	375	393	579	476	59	147	125	19	-5	-31	-84	-84	-84
+ Total Debt	7,607	8,224	6,636	12,404	22,055	26,346	33,542	27,322	24,593	31,402	26,695	25,230	24,987	26,711	24,936
Enterprise Value	-2,164	6,603	4,879	2,669	8,027	14,927	8,091	-2,620	366	24,013	20,170	18,814	17,639	15,059	15,239
Total Capital	9,513	12,171	13,119	25,531	40,636	44,977	52,614	46,494	44,107	45,803	43,015	40,887	41,208	38,125	38,583
Total Debt/Capital (%)	79.96	67.57	50.58	48.58	54.27	58.58	63.75	58.76	55.76	68.56	62.06	61.71	60.64	70.06	64.63
Total Debt / EV	-3.51	1.25	1.36	4.65	2.75	1.76	4.15	-10.43	67.19	1.31	1.32	1.34	1.42	1.77	1.64
EV/Sales	- -	0.68	0.44	0.11	0.25	0.49	0.31	- -	0.02	0.97	0.74	0.69	0.65	0.52	0.52
EV/EBITDA	- -	1.54	1	0.16	0.34	0.79	0.53	- -	0.03	2.11	1.56	1.44	1.53	1.13	1.05
EV/EBIT	- -	1.65	1.08	0.17	0.36	0.85	0.57	- -	0.04	2.42	1.86	1.71	2	1.42	1.3
EV/Cash Flow to Firm	- -	1.91	1.47	0.2	0.37	0.84	0.66	- -	0.04	2.92	1.66	1.92	2.01	1.31	1.4
EV/Free Cash Flow to Firm	- -	1.91	1.47	0.2	0.37	0.84	0.66	- -	0.04	2.92	1.66	1.92	1.88	1.25	1.33
Diluted Market Cap	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Diluted Enterprise Value	-2,148	6,661	4,898	2,770	9,783	18,593	26,013	9,529	13,087	25,424	21,352	19,787	18,818	16,636	17,288
EV per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	19.1	16.06	14.99	14.13	12.08	12.25
TTM Sales	8,385	9,702	11,202	24,890	32,639	30,390	26,107	22,127	22,449	24,689	27,305	27,281	27,116	28,754	29,442
TTM EBITDA	4,092	4,288	4,869	16,315	23,291	18,791	15,410	10,727	10,742	11,407	12,907	13,077	11,531	13,363	14,461
TTM Operating Income	3,790	4,010	4,524	15,265	22,193	17,633	14,124	9,298	9,338	9,927	10,857	10,974	8,838	10,596	11,701
TTM Cash Flow to Firm	3,796	3,452	3,328	13,152	21,825	17,808	12,282	9,154	10,178	8,220	12,134	9,806	8,778	11,506	10,909
TTM Free Cash Flow to Firm	3,796	3,452	3,328	13,152	21,825	17,808	12,282	9,154	10,178	8,220	12,134	9,806	9,363	12,029	11,472

Multiples (USD)

API Chat

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Price/Free Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	1.65	1.08	0.17	0.36	0.85	0.57	- -	0.04	2.42	1.86	1.71	2	1.42	1.3
Enterprise Value	-2,164	6,603	4,879	2,669	8,027	14,927	8,091	-2,620	366	24,013	20,170	18,814	17,639	15,059	15,239
Low Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales	- -	0.68	0.44	0.11	0.25	0.49	0.31	- -	0.02	0.97	0.74	0.69	0.65	0.52	0.52
EV/EBITDA	- -	1.54	1	0.16	0.34	0.79	0.53	- -	0.03	2.11	1.56	1.44	1.53	1.13	1.05
Price/Earnings	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Tangible Book Value Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Average	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow High	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Free Cash Flow Low	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Sales Average	- -	0.69	0.44	0.11	0.3	0.61	1	0.43	0.58	1.03	0.78	0.73	0.69	0.58	0.59
EV/Sales High	- -	0.69	0.44	0.11	0.3	0.61	1	0.43	0.58	1.03	0.78	0.73	0.69	0.58	0.59
EV/Sales Low	- -	0.69	0.44	0.11	0.3	0.61	1	0.43	0.58	1.03	0.78	0.73	0.69	0.58	0.59
EV/EBITDA Average	-0.52	1.55	1.01	0.17	0.42	0.99	1.69	0.89	1.22	2.23	1.65	1.51	1.63	1.24	1.2
EV/EBITDA High	-0.52	1.55	1.01	0.17	0.42	0.99	1.69	0.89	1.22	2.23	1.65	1.51	1.63	1.24	1.2
EV/EBITDA Low	-0.52	1.55	1.01	0.17	0.42	0.99	1.69	0.89	1.22	2.23	1.65	1.51	1.63	1.24	1.2
EV/EBIT Average	-0.57	1.66	1.08	0.18	0.44	1.05	1.84	1.02	1.4	2.56	1.97	1.8	2.13	1.57	1.48
EV/EBIT High	-0.57	1.66	1.08	0.18	0.44	1.05	1.84	1.02	1.4	2.56	1.97	1.8	2.13	1.57	1.48
EV/EBIT Low	-0.57	1.66	1.08	0.18	0.44	1.05	1.84	1.02	1.4	2.56	1.97	1.8	2.13	1.57	1.48
Last Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
High Price	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value Average	-2,148	6,661	4,898	2,770	9,783	18,593	26,013	9,529	13,087	25,424	21,352	19,787	18,818	16,636	17,288
Enterprise Value High	-2,148	6,661	4,898	2,770	9,783	18,593	26,013	9,529	13,087	25,424	21,352	19,787	18,818	16,636	17,288
Enterprise Value Low	-2,148	6,661	4,898	2,770	9,783	18,593	26,013	9,529	13,087	25,424	21,352	19,787	18,818	16,636	17,288

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
Shares Outstanding	1,506	1,519	1,534	1,499	1,422	1,310	1,308	1,282	1,266	1,254	1,254	1,247	1,246	1,246	1,241
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,263	1,262	1,262	1,258	1,255	1,255
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,257	1,256	1,255	1,248	1,247	1,244
Revenue per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	19.64	21.74	21.74	21.73	23.06	23.67
EBITDA per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	9.07	10.28	10.42	9.24	10.72	11.62
Operating Income per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	7.9	8.64	8.74	7.08	8.5	9.41
Basic EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.1	4.96	3.66	4.54	0.38	6.84
Basic EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.07	4.94	3.64	4.5	0.38	6.84
Diluted EPS, GAAP	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.1	4.93	3.64	4.5	0.38	6.78
Diluted EPS from Cont Ops	- -	- -	- -	- -	- -	- -	- -	- -	- -	0.07	4.91	3.62	4.46	0.38	6.78
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	2.74	2.87	2.96	3.05	3.14	3.22
Cash Flow per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.5	9.06	7.23	6.42	8.68	8.05
Free Cash Flow per Basic Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	6.5	9.06	7.23	5.95	8.26	7.6
Cash & Equivalents per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	5.89	5.19	5.09	5.82	9.28	7.73
Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	11.44	13	12.5	13.06	9.22	11.04
Tangible Book Value per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	-18.31	-16.5	-12.75	-9.63	-7.23	-2.15

Gilead Sciences, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)